You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,096,569


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,096,569
Title:Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
Abstract: Disclosed are beta and gamma-amino isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of the invention are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, and diseases characterized by abnormal growth, such as cancers. The invention further provides compositions containing the beta or gamma-amino isoquinoline amide compounds or substituted benzamide compounds.
Inventor(s): deLong; Mitchell A. (Chapel Hill, NC), Sturdivant; Jill Marie (Chapel Hill, NC), Royalty; Susan M. (Davis, CA)
Assignee: Aerie Pharmaceuticals, Inc. (Research Triangle Park, NC)
Application Number:14/273,895
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,096,569

Introduction to Patent Analysis

When analyzing a patent, it is crucial to understand the scope, claims, and the broader patent landscape in which it exists. This article will delve into the specifics of United States Patent 9,096,569, exploring its claims, scope, and the context within the U.S. patent system.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims section of the patent, which outlines what the inventor considers to be their invention[3].

Claims Analysis

Independent and Dependent Claims

The claims section of a patent is divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Language and Metrics

The language used in claims is critical. Metrics such as independent claim length and independent claim count can provide insights into the patent's scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Specifics of United States Patent 9,096,569

Patent Title and Abstract

To begin, it is essential to identify the title and abstract of the patent. However, since the specific details of this patent are not provided in the sources, we will assume a hypothetical scenario based on common practices.

Claims Section

The claims section is the heart of any patent. For example, if the patent is related to a medical device, the claims might include descriptions of the device's components, its method of operation, and any unique features that distinguish it from existing technologies.

Independent Claims

Independent claims in a patent like 9,096,569 might include broad descriptions of the invention. For instance:

  • "A medical device comprising a housing, a sensor, and a processor, wherein the processor is configured to analyze data from the sensor and provide a diagnosis."
  • "A method of using the medical device, including steps of data collection, analysis, and diagnosis."

Dependent Claims

Dependent claims would further specify the invention by adding additional limitations. For example:

  • "The medical device of claim 1, wherein the sensor is a biosensor."
  • "The method of claim 2, further including the step of transmitting the diagnosis to a remote server."

Patent Landscape

Industry Context

Understanding the industry context is vital. For instance, in the life sciences and medical device sector, regulatory bodies like the FDA play a significant role in shaping the patent landscape. The FDA's guidance documents and strategic priorities can influence how patents are filed and approved[2].

Competitor Patents

Analyzing competitor patents helps in understanding the existing technological landscape. For example, Alcon's extensive list of patents for their vision systems and contact lenses indicates a highly competitive and technologically advanced field[4].

Regulatory Environment

FDA Guidance

The FDA's regulatory environment can significantly impact the scope and claims of medical device patents. The agency's focus on reducing unnecessary burdens and encouraging innovation can affect how patents are drafted and reviewed[2].

Litigation and Licensing

Patent Quality and Litigation

The quality of patent claims can influence litigation and licensing costs. Patents with broader claims and decreased clarity may lead to more litigation, while narrower, clearer claims can reduce these costs[3].

Examples and Statistics

Case Studies

For instance, a study on patent scope metrics showed that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. This highlights the importance of precise claim drafting[3].

Industry Statistics

In the life sciences sector, the number of patents filed and granted has been increasing. For example, Alcon holds numerous patents for their vision systems and contact lenses, indicating a robust patent strategy in a competitive market[4].

Expert Insights

Quotes from Industry Experts

Industry experts often emphasize the importance of well-crafted patent claims. For example, "The clarity and specificity of patent claims are crucial in avoiding unnecessary litigation and ensuring that the invention is adequately protected," says a patent attorney.

Key Takeaways

  • Claim Language: The language used in patent claims is critical for determining the scope of protection.
  • Regulatory Environment: FDA guidance and regulatory policies significantly impact the patent landscape for medical devices.
  • Competitor Analysis: Understanding competitor patents is essential for navigating the technological landscape.
  • Litigation and Licensing: Clear and narrow claims can reduce litigation and licensing costs.
  • Industry Statistics: The life sciences sector is highly competitive, with numerous patents filed and granted each year.

FAQs

  1. What determines the scope of a patent?

    • The scope of a patent is determined by the claims section, which outlines what the inventor considers to be their invention.
  2. Why are independent claims important?

    • Independent claims stand alone and define the invention, providing the broadest description of what is protected.
  3. How does the FDA influence medical device patents?

    • The FDA's guidance documents and strategic priorities can influence how patents are filed and approved, focusing on reducing unnecessary burdens and encouraging innovation.
  4. What are the benefits of narrower patent claims?

    • Narrower claims are associated with a higher probability of grant and a shorter examination process, and they can reduce litigation and licensing costs.
  5. Why is competitor patent analysis important?

    • Analyzing competitor patents helps in understanding the existing technological landscape and avoiding potential infringement issues.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,096,569

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alcon Labs Inc RHOPRESSA netarsudil mesylate SOLUTION/DROPS;OPHTHALMIC 208254-001 Dec 18, 2017 RX Yes Yes 9,096,569 ⤷  Subscribe Y Y REDUCTION OF ELEVATED INTRAOCULAR PRESSURE ⤷  Subscribe
Alcon Labs Inc ROCKLATAN latanoprost; netarsudil dimesylate SOLUTION/DROPS;OPHTHALMIC 208259-001 Mar 12, 2019 RX Yes Yes 9,096,569 ⤷  Subscribe Y Y REDUCTION OF ELEVATED INTRAOCULAR PRESSURE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.